Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2000 Jan;84(1):40–47. doi: 10.1136/bjo.84.1.40

Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study

J Roider 1, R Brinkmann 1, C Wirbelauer 1, H Laqua 1, R Birngruber 1
PMCID: PMC1723228  PMID: 10611098

Abstract

BACKGROUND—Subthreshold (retinal pigment epithelium) photocoagulation is a new photocoagulation method, which treats the retinal pigment epithelium (RPE) and avoids damage to the neural retina. The initial results in this prospective pilot study on various macular diseases are presented.
METHODS—12 patients with diabetic maculopathy (group I), 10 with soft drusen (group II), and four with central serous retinopathy (CSR) (group III) were treated and followed up for 1 year. Treatment was achieved using a train of repetitive short laser pulses (1.7 µs) of a green Nd:YLF laser (parameters: 527 nm, 100 and 500 pulses, repetition rate: 500 Hz, spot size: 160 µm, energies: 70-100 µJ). Laser energy was based on the visibility of test lesions on fluorescein angiography (50-130 µJ). Patients were examined at various times by ophthalmoscopy, fluorescein and ICG angiography, and infrared imaging.
RESULTS—After 6 months hard exudates disappeared in six out of nine patients in group I and leakage disappeared in six out of 12 diabetic patients. In group II drusen were less in seven out of 10 patients. In group III serous detachment disappeared in three out of four cases. Visual acuity was stable in all cases. None of the laser lesions was clinically visible immediately. After 1 day most lesions were visible as yellowish RPE depigmentation. After 3 months some of the lesions were visible as hyperpigmented areas but most were not. Fluorescein angiography showed leakage only in the first week. Infrared imaging showed that most lesions can be visualised in groups I and II after a period longer than 1 week as hyperreflective areas.
CONCLUSION—This study showed that subthreshold (RPE) photocoagulation is effective in some cases of diabetic maculopathy, drusens, and in CSR. Visibility of laser burns is not always necessary in the treatment of macular diseases presented here. Infrared imaging is an effective and non-invasive way of visualising subthreshold (RPE) laser burns.



Full Text

The Full Text of this article is available as a PDF (327.7 KB).

Figure 1  .

Figure 1  

Open in a new tab

Early (A) and late (B) phase of test exposures in the lower part of the macula with various number of pulses and energy, showing RPE disruption.

Figure 2  .

Figure 2  

Open in a new tab

Fundus picture of a 48 year old diabetic patient with hard exudates (A). The corresponding fluorescein angiogram shows diffuse leakage (B). Angiogram 2 hours after a grid and a focal treatment to the area of hard exudates was performed (C). Fundus image 6 months after photocoagulation (D). Apart from two areas of hyperpigmentation (arrows) no laser scars can be seen.

Figure 3  .

Figure 3  

Open in a new tab

Late phase (10 minutes) of a diabetic patient showing clinically significant exudation before treatment (A). The corresponding angiogram 1 day after treatment (B) shows RPE disruption due to the laser effects. Early (C) and late (D) phase of the angiogram 6 months later: no exudation is detectable in the late phase (10 minutes) (D), however microaneurysms are still visible.

Figure 4  .

Figure 4  

Open in a new tab

Fundus image of a patient with soft drusen before (A) and 2 hours after a grid treatment has been applied to the temporal macula (B). Fundus image 1 year after treatment (C). Most drusen have disappeared. The photocoagulation pattern is shown in Figure 7B, visible as bright hyperfluorescent areas due to disruption of the outer blood-retinal barrier.

Figure 5  .

Figure 5  

Open in a new tab

Fundus image before (A) and 6 months after subthreshold RPE treatment (B). A change in the drusen pattern is notable (arrows).

Figure 6  .

Figure 6  

Open in a new tab

Fundus image of a patient with recurrent central serous retinopathy before (A) and 2 weeks (B) after photocoagulation Corresponding fluorescein angiogram before (C), 2 hours (D), and 2 weeks (E) after photocoagulation. Exudation has disappeared after 2 weeks. Note laser scars (arrow) of previously done conventional treatment.

Figure 7  .

Figure 7  

Open in a new tab

Fluorescein angiogram 2 hours (A) and 4 hours (B) after photocoagulation. Test exposures (parameters: 500 pulses each 70 µJ and 100 pulses each 70 µJ) have been applied to the test area. While 2 hours after treatment (A) one laser exposure (parameter: 500 pulses, 70 µJ) is visible (arrow), 4 hours after treatment (B) all four laser exposures have led to disruption of the RPE barrier (arrow).    

Figure 8  .

Figure 8  

Open in a new tab

Fundus image of a patient treated for soft drusen 6 months after treatment (A). The photocoagulation pattern is shown in (B). Corresponding infrared images 1 day (C) and 1 week (D) after treatment. While no laser lesions are visible after 1 day all laser exposures can be visualised after 1 week (D).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birngruber R., Gabel V. P., Hillenkamp F. Experimental studies of laser thermal retinal injury. Health Phys. 1983 May;44(5):519–531. doi: 10.1097/00004032-198305000-00006. [DOI] [PubMed] [Google Scholar]
  2. Bresnick G. H. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology. 1983 Nov;90(11):1301–1317. doi: 10.1016/s0161-6420(83)34388-8. [DOI] [PubMed] [Google Scholar]
  3. Del Priore L. V., Glaser B. M., Quigley H. A., Green W. R. Response of pig retinal pigment epithelium to laser photocoagulation in organ culture. Arch Ophthalmol. 1989 Jan;107(1):119–122. doi: 10.1001/archopht.1989.01070010121039. [DOI] [PubMed] [Google Scholar]
  4. Friberg T. R., Karatza E. C. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology. 1997 Dec;104(12):2030–2038. doi: 10.1016/s0161-6420(97)30061-x. [DOI] [PubMed] [Google Scholar]
  5. Hergott G. J., Sandig M., Kalnins V. I. Cytoskeletal organization of migrating retinal pigment epithelial cells during wound healing in organ culture. Cell Motil Cytoskeleton. 1989;13(2):83–93. doi: 10.1002/cm.970130203. [DOI] [PubMed] [Google Scholar]
  6. Lappin P. W., Coogan P. S. Relative sensitivity of various areas of the retina to laser radiation. Arch Ophthalmol. 1970 Sep;84(3):350–354. doi: 10.1001/archopht.1970.00990040352015. [DOI] [PubMed] [Google Scholar]
  7. Marshall J. Interactions between sensory cells, glial cells and the retinal pigment epithelium and their response to photocoagulation. Dev Ophthalmol. 1981;2:308–317. doi: 10.1159/000395340. [DOI] [PubMed] [Google Scholar]
  8. Roider J., Hillenkamp F., Flotte T., Birngruber R. Microphotocoagulation: selective effects of repetitive short laser pulses. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8643–8647. doi: 10.1073/pnas.90.18.8643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Roider J., Lindemann C., el-Hifnawi el-S, Laqua H., Birngruber R. Therapeutic range of repetitive nanosecond laser exposures in selective RPE photocoagulation. Graefes Arch Clin Exp Ophthalmol. 1998 Mar;236(3):213–219. doi: 10.1007/s004170050067. [DOI] [PubMed] [Google Scholar]
  10. Roider J., Michaud N. A., Flotte T. J., Birngruber R. Response of the retinal pigment epithelium to selective photocoagulation. Arch Ophthalmol. 1992 Dec;110(12):1786–1792. doi: 10.1001/archopht.1992.01080240126045. [DOI] [PubMed] [Google Scholar]
  11. Roider J., Michaud N., Flotte T., Birngruber R. Histologie von Netzhautläsionen nach kontinuierlicher Bestrahlung und nach selektiver Mikrokoagulation des retinalen Pigmentepithels. Ophthalmologe. 1993 Jun;90(3):274–278. [PubMed] [Google Scholar]
  12. Wallow I. H., Birngruber R., Gabel V. P., Hillenkamp F., Lund O. I. Netzhautreaktionen nach Intensivlichtbestrahlung. Teil I: Schwellenläsionen. Experimentelle, morphologische und klinische Untersuchungen über pathologische und therapeutische Wirkungen von Laserlicht und von weissem Licht. Adv Ophthalmol. 1975;31:159–232. [PubMed] [Google Scholar]
  13. Wallow I. H., Tso M. O. Repair after xenon arc photocoagulation. 2. A clinical and light microscopic study of the evolution of retinal lesions in the rhesus monkey. Am J Ophthalmol. 1973 Apr;75(4):610–626. [PubMed] [Google Scholar]
  14. Wolbarsht M. L., Landers M. B., 3rd The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model. Ophthalmic Surg. 1980 Apr;11(4):235–245. [PubMed] [Google Scholar]
  15. Yamamoto C., Ogata N., Yi X., Takahashi K., Miyashiro M., Yamada H., Uyama M., Matsuzaki K. Immunolocalization of transforming growth factor beta during wound repair in rat retina after laser photocoagulation. Graefes Arch Clin Exp Ophthalmol. 1998 Jan;236(1):41–46. doi: 10.1007/s004170050040. [DOI] [PubMed] [Google Scholar]
  16. Yoshimura N., Matsumoto M., Shimizu H., Mandai M., Hata Y., Ishibashi T. Photocoagulated human retinal pigment epithelial cells produce an inhibitor of vascular endothelial cell proliferation. Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1686–1691. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES